Murex challenge

* The House of Lords is considering an application by Murex Diagnostics to challenge a Court of Appeal ruling made last October in a patent infringement action relating to kits designed for the treatment of hepatitis. Murex in defence has argued that the Chiron Corporation abused its dominant market position and charged unfairly high prices, contrary to Article 86 of the Treaty of Rome.